KREON

This brand name is authorized in Austria, Croatia, Estonia, Germany, Lithuania, Poland, Romania, Spain, Turkey.

Active ingredients

The drug KREON contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 8MYC33932O - PANCRELIPASE LIPASE
 

Pancreatin when reaching the small intestine disintegrates (at pH>5.5) to release enzymes with lipolytic, amylolytic and proteolytic activity to ensure the digestion of fats, starches and proteins. The products of pancreatic digestion are then either absorbed directly, or following further hydrolysis by intestinal enzymes.

 
Read more about Pancreatin
2
UNII YOJ58O116E - PANCRELIPASE AMYLASE
 

Pancreatin when reaching the small intestine disintegrates (at pH>5.5) to release enzymes with lipolytic, amylolytic and proteolytic activity to ensure the digestion of fats, starches and proteins. The products of pancreatic digestion are then either absorbed directly, or following further hydrolysis by intestinal enzymes.

 
Read more about Pancreatin
3
UNII 3560D81V50 - PANCRELIPASE PROTEASE
 

Pancreatin when reaching the small intestine disintegrates (at pH>5.5) to release enzymes with lipolytic, amylolytic and proteolytic activity to ensure the digestion of fats, starches and proteins. The products of pancreatic digestion are then either absorbed directly, or following further hydrolysis by intestinal enzymes.

 
Read more about Pancreatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A09AA02 Multienzymes (lipase, protease etc.) A Alimentary tract and metabolism → A09 Digestives, incl. enzymes → A09A Digestives, incl. enzymes → A09AA Diastase
Discover more medicines within A09AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 04437981, 04437998, 04529306, 04946814, 04946837, 05491089, 06429626, 06429632, 06429649, 07009286, 07202899, 07202907, 07202913, 09515243, 09515289, 09528145, 09671629, 14327638, 14327644, 14327673, 14327710, 14327727, 14327733
EE Ravimiamet 1044469, 1044470, 1063707, 1063729, 1063763, 1063774, 1234684, 1234695, 1234707, 1741766, 1741777, 1741788, 1741799, 1741801, 1741812, 1741889, 1741890, 1741902, 1741913, 1741924
ES Centro de información online de medicamentos de la AEMPS 58719, 63832, 77205, 83862
HR Agencija za lijekove i medicinske proizvode HR-H-401150260, HR-H-423800596, HR-H-724454677
LT Valstybinė vaistų kontrolės tarnyba 1002796, 1002798, 1022289, 1022290, 1063027, 1063028, 1063029, 1063030, 1063157, 1063158, 1075083, 1075084, 1075085
PL Rejestru Produktów Leczniczych 100035580, 100217191, 100235600, 100257960, 100275930, 100298999, 100349509, 100350547, 100357288, 100359212, 100365550, 100386166, 100386210, 100398809, 100414046, 100429295
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68326001, W68326003, W68326004, W68327001, W68327003, W68327004, W68657001, W68657002, W68657003, W68657004, W68657005, W68657006
TR İlaç ve Tıbbi Cihaz Kurumu 8699548165030, 8699548235023, 8699559160017, 8699820160371, 8699820160388, 8699820160401, 8699820160418

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.